Markets:

Overview

News

Currencies

International

Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

5.976 +0.096 (+1.64%)

Streaming Delayed Price Updated: 2:56 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Shares of Bausch Health Jumped on Friday ↗

July 07, 2023

Global investment powerhouse KKR will be providing the healthcare company with increased liquidity.

Via The Motley Fool

OraPharma to Participate in the First-Ever Research and Technology Pavilion Sponsored by Pacific Dental Services(R) at the American Dental Hygienists' Association (ADHA(R)) Annual Conference

July 07, 2023

Via ACCESSWIRE

Bausch Health Enters Into $600 Million Financing Facility With KKR

July 07, 2023

Via ACCESSWIRE

Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis ↗

June 30, 2023

Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:

Via Benzinga

Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)

June 30, 2023

Via ACCESSWIRE

Salix to Present Data from XIFAXAN(R) (Rifaximin) Clinical Research at EASL's International Liver Congress(TM) 2023

June 19, 2023

Via ACCESSWIRE

Why Bausch Health Companies Stock Is Tanking Today ↗

June 06, 2023

The never-ending saga over generic Xifaxan is weighing on the drugmaker's stock today.

Via The Motley Fool

Why Shares of Bausch Health Soared Wednesday ↗

May 17, 2023

The company won a big patent fight with a generic-drug maker.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023 ↗

June 16, 2023

Via Benzinga

Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 06, 2023

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement for planned purchase of fintech assets of GoLogiq.

Via Benzinga

Bausch Health Announces 2023 Annual Meeting of Shareholder Results

May 17, 2023

Via ACCESSWIRE

Salix Pharmaceuticals to Deliver Podium Presentation at Digestive Disease Week(R) 2023

May 08, 2023

Via ACCESSWIRE

Why Bausch Health Stock Is Tumbling Today ↗

May 04, 2023

Bausch Health Companies Inc (NYSE: BHC) reported Q1 FY23 revenues of $1.94 billion, up 1% Y/Y, up 4% organic basis, missing the consensus

Via Benzinga

Coinbase, Blue Bird, Tingo Group And Other Big Stocks Moving Lower On Tuesday ↗

June 06, 2023

U.S. stocks traded mixed, with the Nasdaq Composite rising around 0.2% on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Bausch Health Responds to Norwich's ANDA Tentative Approval and Lawsuit Against United States Food and Drug Administration

June 06, 2023

Via ACCESSWIRE

Zoetis Declares New Dividend, Hinting At Undervaluation

May 18, 2023

Zoetis shareholders woke up to news of JAB's acquisition of Pumpkin, a per insurance platform where Zoetis owns a minority stake. 2023 outlooks suggest a rally

Via MarketBeat

Bausch Health Options Traders: Stock Will Remain Below This Level Through July Expiration ↗

May 18, 2023

Bausch Health Companies Inc. (NYSE: BHC) shares rose sharply on Wednesday.

Via Benzinga

Recap: Bausch Health Companies Q1 Earnings ↗

May 04, 2023

Via Benzinga

Bausch Health Announces First-Quarter 2023 Results

May 04, 2023

Via ACCESSWIRE

Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel

May 01, 2023

Via ACCESSWIRE

New Clinical Study Suggests the Use of OraPharma’s ARESTIN(R) (minocycline HCl) Microspheres, 1mg May Decrease Certain Pathogens in Adults with Periodontitis

May 18, 2023

Via ACCESSWIRE

U.S. District Court Upholds Final Judgment for XIFAXAN(R) 550 mg That Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029

May 17, 2023

Via ACCESSWIRE

Bausch Health Observes Mental Health Awareness Month

May 10, 2023

Via ACCESSWIRE

US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism' ↗

May 04, 2023

With so much going on in the banking space, sentiment continues to remain jittery. The index futures point to a mixed opening on Thursday, as the tech space exuded optimism ahead of Apple, Inc.’s...

Via Benzinga

Salix Partners with the Colorectal Cancer Alliance on Community Screening Program

April 24, 2023

Via ACCESSWIRE

Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 04, 2023

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44.

Via Benzinga

New Artificial Intelligence Tool Can Diagnose Colon Cancer

May 03, 2023

A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and...

Via PressReach

Topics Artificial Intelligence Death

Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value ↗

April 25, 2023

Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a

Via Benzinga

Bausch Health to Announce First-Quarter 2023 Results on May 4

April 13, 2023

Via ACCESSWIRE

New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider

April 04, 2023

Via ACCESSWIRE

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.